Your outcomes are a sample
Some of what your building calls a good outcome is a selection effect. In 2029 you will find out how much.
Starting with residents admitted on or after October 1, 2029, you'll submit an MDS on every resident receiving covered skilled care, whatever the payer. Most of the reaction has treated that as a paperwork problem. One national association called it administrative burden. Another called it a more complete picture of provider performance. Both are accurate, and the second one is the half with teeth in it.
Here's what I see. Your short-stay quality measures, including the discharge function score that just entered value-based purchasing, are calculated off your Medicare Part A stays. Fifty-five percent of eligible Medicare beneficiaries are now in Medicare Advantage. Your own building's split is whatever it is, but for most, the residents feeding those measures are no longer the whole skilled census. And they are not a random slice of it.
Your Medicare Advantage residents get shorter authorizations and more pressure toward a discharge date set somewhere other than your building. Those are the exact conditions that produce an incomplete functional recovery. They're the stays where GG change is thinnest.
Right now most of those stays don't reach the measure. In 2029 they will.
None of us knows how large our own share is, and three years is not much runway for finding out.
And the fix isn't a reporting project. Your MDS team can capture an MA resident's function accurately today, but capturing it doesn't move it. What moves it is whether anybody was working the reasons that resident missed therapy while she was still in the building, and on a short authorization that window is very small.
The burden is a 2029 problem. The number underneath it is a today problem.
If you ran your discharge function score across your whole skilled census instead of just Part A, do you know which way it would move?
Follow for the next one: Dr. Raj Desai · Precision Pain & Rehabilitation Management on LinkedIn.